Apr 18 |
US FDA mandates label updates on CAR-T cancer therapies
|
Apr 18 |
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
Apr 18 |
Gilead Sciences Publishes 2023 ESG Impact Report
|
Apr 18 |
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
|
Apr 17 |
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
|
Apr 16 |
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
|
Apr 16 |
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
|
Apr 15 |
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
|
Apr 15 |
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
|
Apr 15 |
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG
|